Young Chinese vaccine developer strives to defeat COVID-19

Liang Hongyang, head of the Scientific Research Management Department of Sinopharm’s Beijing Institute of Biological Products, cut short his vacation and headed back to his office in Beijing without a second thought after he received a call to kick off a COVID-19 vaccine development project on Chinese New Years Eve, an occasion when people are supposed to reunite with their family.

Faced with a raging virus, he led his team in round-the-clock scientific research with determination and created his company’s first COVID-19 vaccine, which brought hope to the global population.

“Keep on striving even if you are shedding tears, ” Liang said to Chinese youth, looking back at his battle against the virus.